News

Prefilled pens offer convenience compared to using a syringe, and may be for those who don’t choose to wear an insulin pump device. Plastic, prefilled insulin pens are an option that makes ...
Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of Minnesota over the pricing of its insulin products by agreeing to cap costs at $35 per month. Under the settlement ...
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
The sudden departure of Novo Nordisk chief executive Lars Fruergaard Jørgensen comes not amid scandal or strategic calamity, but a less fashionable misstep: disappointing the stock market.
Novo Nordisk A/S, together with its subsidiaries ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes ...
Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.
Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide products, Wegovy (obesity) and Ozempic (diabetes). Building upon this ...
Danish drugmaker Novo Nordisk A/S is preparing to launch its blockbuster weight-loss drug Wegovy in India within the next several weeks, sources told Moneycontrol. The move thrusts the company ...
Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline weight-loss result has sent its shares into a sharp decline. The stock ...
Industry News: . Eli Lilly's Connected Pen Launch: In early 2025, Eli Lilly released a Bluetooth-enabled smart insulin pen in select European markets, with a U.S. launch expected by Q3 2025 ...